These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9767795)

  • 21. Quinolones: structure-activity relationships and future predictions.
    Tillotson GS
    J Med Microbiol; 1996 May; 44(5):320-4. PubMed ID: 8636945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parenteral fluoroquinolones prevent translocation of enterobacteria following combined liver-small bowel transplantation in pigs.
    Privitera G; Rossi G; Conte E; Gatti S; Matinato C; Reggiani P
    Transplant Proc; 1996 Oct; 28(5):2669-70. PubMed ID: 8908003
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metaphylaxis and therapy of the MMA syndrome of sows with Baytril].
    Schöning G; Plonait H
    Dtsch Tierarztl Wochenschr; 1990 Jan; 97(1):5-10. PubMed ID: 2311533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fluoroquinolones and their importance in modern chemotherapy of infectious diseases].
    Padeĭskaia EN
    Antibiot Khimioter; 1989 Jul; 34(7):514-21. PubMed ID: 2818083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic focus. The fluoroquinolones.
    James DG
    Br J Clin Pract; 1989 Feb; 43(2):66-7. PubMed ID: 2679837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
    Tozawa K; Washida H; Honma H; Kang K; Yamada Y
    Hinyokika Kiyo; 1993 Sep; 39(9):801-5. PubMed ID: 8213373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse effects of fluoroquinolones.
    Shimada J; Hori S
    Prog Drug Res; 1992; 38():133-43. PubMed ID: 1609111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial hypertension and ciprofloxacin.
    Milanlioglu A; Torlak PT
    Neurol India; 2011; 59(2):302-3. PubMed ID: 21483143
    [No Abstract]   [Full Text] [Related]  

  • 31. Photosensitivity reactions caused by lomefloxacin hydrochloride: a multicenter survey.
    Arata J; Horio T; Soejima R; Ohara K
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3141-5. PubMed ID: 9835505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and residue studies of quinolone compounds and olaquindox in poultry.
    Anadón A; Martinez-Larrañaga MR; Diaz MJ; Velez C; Bringas P
    Ann Rech Vet; 1990; 21 Suppl 1():137S-144S. PubMed ID: 2080842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
    Livermore DM; Hope R; Reynolds R; Blackburn R; Johnson AP; Woodford N
    J Antimicrob Chemother; 2013 Nov; 68(11):2667-74. PubMed ID: 23766490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
    Lipsky BA; Dorr MB; Magner DJ; Talbot GH
    Clin Ther; 1999 Jan; 21(1):148-59. PubMed ID: 10090432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinolone antimicrobial agents.
    Neu HC
    Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical and microbiological study of the preparation perfloxacin in treating urologic infections].
    Dragiev D; Savov E; Lilov A; Tsenova Z; Saltirov I; Atanasova I
    Khirurgiia (Sofiia); 1993; 46(4):49-51. PubMed ID: 8041098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks associated with the therapeutic use of fluoroquinolones.
    Stahlmann R; Lode HM
    Expert Opin Drug Saf; 2013 Jul; 12(4):497-505. PubMed ID: 23651367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae: a multicenter study].
    Coban AY; Nohut OK; Tanrıverdi Çaycı Y; Bayramoğlu G; Pirinççiler M; Cetinkaya E; Cekiç Cihan C; Bozdoğan B; Durupınar B
    Mikrobiyol Bul; 2012 Jul; 46(3):366-74. PubMed ID: 22951649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of quinolones--a meta-analysis of pregnancy outcomes.
    Bar-Oz B; Moretti ME; Boskovic R; O'Brien L; Koren G
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):75-8. PubMed ID: 19181435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.